Recent Posts
Social•Jan 12, 2026
AI Giants Race Into Healthcare Sector
A few days ago it was @OpenAI, now @Anthropic. The others soon. The push into healthcare https://t.co/5jVJVJ39MH
By Eric Topol
Social•Jan 12, 2026
Heart Scarring, Not Training, Drives Arrhythmias in Veteran Athletes
Occurrence of ventricular arrhythmias in endurance male athletes age 50+ correlated with prior heart scarring (myocardial fibrosis), not exercise patterns https://t.co/CTWLLEZVSI https://t.co/fqVhTkV7BN
By Eric Topol
Social•Jan 9, 2026
CHIP Clones Raise Cardiovascular Risk in Cancer Survivors
More evidence that blood stem cell clones (CHIP), common with increasing age, increase the risk of cardiovascular events, from people treated with cancer https://t.co/56YDjxshjg https://t.co/kdUksoCFmI
By Eric Topol
Social•Jan 9, 2026
Red Blood Cells Drive Vascular Damage in Long‑Term Type 2 Diabetes
Implicating red cells as an underpinning of the vascular damage seen with long duration Type 2 diabetes https://t.co/FzvmreCtn7 https://t.co/MdgpHmpRvo
By Eric Topol
Social•Jan 9, 2026
APOE Ε3/Ε4 Alleles Drive Majority of Alzheimer’s Cases
A new report claims that the APOE gene alleles accounts for the vast majority of Alzheimer's cases: "Without strong underlying risks from APOE ε3 and ε4, almost all AD and half of all dementia would not occur." https://t.co/KgRFx36WOn
By Eric Topol
Social•Jan 8, 2026
Multi-Omic Atlas Shows Women’s Stronger Immunity, Age‑Related Decline
We're learning more about our immune system from a new, comprehensive, multi-omic atlas in @ScienceMagazine today, such as the stronger immune system in women and the age-related features of immunosenescence https://t.co/4B85BwohBb https://t.co/DHNIUKcQmE
By Eric Topol
Social•Jan 8, 2026
AlphaFold Sparks Surge in Genome-Wide Drug Discovery
In the post-AlphaFold era, drug discovery is on a tear —Genome-wide virtual screening @ScienceMagazine https://t.co/GPyjSK6PcM —Transforming the industry in many ways @TheEconomist https://t.co/ppAMkbFqMp
By Eric Topol
Social•Jan 8, 2026
AI-Driven Tracking of Tumor Evolution Reshapes Cancer Therapy
The plan to revolutionize cancer treatment by tracking and responding to evolution of tumor, emergence of resistance, and multimodal AI https://t.co/9PhOrtkiBM @Cancer_Cell @ARPA_H
By Eric Topol
Social•Jan 8, 2026
Cellular Reprogramming Paves Path to Anti‑Aging Organs
Anti-aging and organ rejuvenation strategies, a review https://t.co/ZycCqjZwKk @CellStemCell Figure summary of cellular reprogramming efforts https://t.co/YKgGKukuYb
By Eric Topol
Social•Jan 8, 2026
Treg Breakthroughs: Nobel‑winning Science Moves Toward Clinics
The science of regulatory T cells (Tregs) got the @NobelPrize last year. Now a first-rate review of where they are headed in the clinical arena https://t.co/4xjNAeG3MV https://t.co/MZCDyBc4jq
By Eric Topol
Social•Jan 8, 2026
Low‑dose IL‑2 Curbs Artery Inflammation, Boosts Tregs
Blocking artery inflammation and increasing Treg cells in a small randomized trial with low-dose interleukin-2 https://t.co/ecEEnwUuhr
By Eric Topol
Social•Jan 8, 2026
2026 Marks First AI Prescription Renewals and ChatGPT Health
2026 is off with two new precedents in health and medical AI —@doctronic given green light in Utah for AI prescription renewals, pilot study 250 patients https://t.co/EQ3fmqWwyz —ChatGPT Health initiated https://t.co/VOvd3wVkeR @fidjissimo Both need prospective study, rigorous independent assessment, and report of results
By Eric Topol
Social•Jan 7, 2026
AI Predicts Hundreds of Diseases Years Ahead From Health Data
Large health models and predicting diseases —In September, >1,200 diseases predicted and when, by EHR and lifestyle factors, for 20-years forward https://t.co/31prJJL1v6 —Yesterday, >130 diseases were predicted from 1 night of sleep data and EHR (Figure) https://t.co/ebHlmaWjfK
By Eric Topol
Social•Jan 7, 2026
Two Novel Strategies Supercharge Cancer Immunity
2 new ways to get the immune system revved up vs cancer —intratumor vaccination https://t.co/PUWOHy8Dkw —bacterial outer membrane vesicles https://t.co/2xC5PAC8OG
By Eric Topol
Social•Jan 7, 2026
High Lp(a) Raises Long‑Term Risk; Therapies Coming
The risk of high lipoprotein A [Lp(a)] in nearly 28,000 healthy women followed for 30 years. Fortunately, after waiting for decades, we will have drugs vs Lp(a) soon to reduce this risk https://t.co/SfXTtpaV0i https://t.co/PdykVP6nKB
By Eric Topol
Social•Jan 7, 2026
Mitochondria Transfer From Glia Offers Neuropathy Therapy
Discovery of a new potential approach for treating peripheral neuropathy: mitochondria transfer from satellite glial cells to neurons @Nature https://t.co/EZxAkbi6kk https://t.co/I4td8aScPP
By Eric Topol
Social•Jan 7, 2026
Atrial Fibrillation Drives Cognitive Decline, Not Prevented by Blood Thinners
Atrial fibrillation and cognitive decline. Blood thinners don't help. Possible explanations not mentioned here include less brain clearance of metabolic waste products with this heart rhythm, recently documented https://t.co/IWzR05JaBN https://t.co/5UA4vcW3GO
By Eric Topol